Blinatumomab Followed by High-dose Chemotherapy for Ph-negative Acute Lymphoblastic Leukemia (ALL)
Conditions: Lymphoblastic Leukemia, Acute, Adult; Ph Negative ALL; Newly Diagnosed Intervention: Drug: Blinatumomab Sponsors: Institute of Hematology and Blood Transfusion, Czech Republic; CZECRIN - Czech Clinical Research Infrastructure Network Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Blood Transusion | Chemotherapy | Czechia Health | Hematology | Leukemia | Research